skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i,

Can I get your thoughts on Personalis, Inc.? It has pulled back since the IPO. What do you think of the risk/reward ratio? Would it compare to Guardant?

TIA!
Read Answer Asked by Wayne on July 08, 2019
Q: Does the legal action started have any possibility? Most of these issues end up dying a slow death. Shareholders have been deceived but whether there is sufficient fact here is questionable as is the usual response of the TSX and authorities to simply allow managements actions that are clearly against minority shareholders wishes. It would be nice to see some teeth in investor law.
Read Answer Asked by david on July 08, 2019
Q: Hi 5i team,
Thank you for your answer on Eidos Therapeutic on 21st, June. I own this stock and has gone up 30% + thanks to your positive comment ( at least the ceo has bought 28m in shares), I usually hold on to my winner and let it runs, but I do not understand why it gone up so fast within a short period of time with no news.

As stated in your answer, the company has no revenue and is still losing money. Do you see further upside for this stock ? Should I continue to hold ?

Thank you for your excellent service and helpful advice as always.

Read Answer Asked by Pui on July 05, 2019
Q: Thinking of investing in US drug company GIL. The whole sector seems hammered which I think may be a result of the US presidential race...I'm more of a " Tell me what they're up to " kind of investor as opposed to earnings per share and how many of their last quarters they've beat......Would like to know the good and bad about GIL ..... And one important factor... Are they in any way effected by the various state sponsored opioid lawsuits . I don't want any where near any of those companies. It looks like they may be in a lot of trouble. .... Of any country's drug companies would it be 5I's choice ? If not what would be 5I's current favorite ? Thank you for your sound advice......
Read Answer Asked by Garth on July 04, 2019
Q: The CEO/founder has applied to put all of his 52% ownership of the company up for sale. I understand insiders selling a part of their shares, but I've never come across selling all of them. My first thought is some company disaster, but I imagine, in that scenario, an insider would feed them slowly into the market to avoid suspicion. Your opinion please.
Read Answer Asked by sandy on June 27, 2019
Q: AGN has received a $188.24/s stock+cash offer from ABBV, yet (pre-market) its shares aren't breaking above $173. In this sort of situation, isn't it more typical for the share price to overshoot the offer (given the chance of another bid)? Or is the market doubtful that any deal will be completed?
Read Answer Asked by John on June 25, 2019
Q: Hi 5i,
I have some USD set aside to purchase Pfizer (PFE:US) and have a window of up until about Aug.5th give or take, having missed the latest dividend. So, I am in no real hurry. My question is: should I just proceed and purchase now or wait to see if there is any kind of pull-back presenting a better entry point between now and August? I see it has continued to grind higher over the past while.
Your thoughts would be appreciated.
Thanks!!
Cheers,
Mike
Read Answer Asked by Mike on June 25, 2019
Q: As the opportunity arises, I need to lessen my overweight position in SIS. Would SYK be an attractive substitute in a sector that, like SIS, is right for the times as the general population ages and are increasingly in deteriorating physical shape. Is there any other company with these dynamics that I should look at?
Read Answer Asked by Geoffrey on June 24, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!